On October 8, Shanghai Lishan Biopharmaceutical Co., Ltd. Zhangjiang Bio-Drug Research and Development Center officially launched the preclinical research work of Type 2 diabetes (T2D) pipeline, which is another blockbuster pipeline launched after Li
On the morning of September 7, 2023, in the government office building of Pudong New Area, Shanghai Lishan Biomedicine Co., LTD., Tian Runyin, deputy general manager of Shanghai Lishan Biomedicine Co., Ltd. reported the latest situation of its resear
In an adult body, the number of gut microbes is as high as 10 to the 12-14 power, and the total weight is about 2-3 kilograms, which is equivalent to an organ of the human body. Scientific research has found that these microbes are closely related to
On August 1, 2023, the intelligent microbiome school-enterprise joint laboratory officially landed in Shanghai Medical College of Fudan University, Fudan University Intelligent Medical Research Institute and Shanghai Lishan Biomedicine Co., Ltd. reac
Shanghai Public Network Anbei 31011502402974